SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

STRIDES PHARMA SCIENCE

BSE: 532531 19 Oct 2025
Healthcare
₹ 817.05
STRIDES PHARMA SCIENCE LIMITED specializes in Pharmaceuticals within the Healthcare sector.

STRIDES PHARMA SCIENCE - Share Price & Details

Market Cap
₹7,517
High /Low
972.0 / 513.0
Stock P/E
20.1
Book Value
₹277.0
Dividend Yield
0.49
ROCE
14.7
ROE
₹151.0
Face Value
10.0
PEG Ratio
0.13
EVEBITDA
₹10.4
Debt
1,880
CMP / FCF
19.8
Debt to equity
₹0.74
NP Ann
3,598
High price all time
972.0
Piotroski score
₹7.0
Graham Number
480.0
No. Eq. Shares
9.22
Net CF
₹-48.5
Net profit
354
Price to book value
2.95
Interest Coverage
₹3.1
Low price all time
26.0
Industry PE
33.0
Reserves
₹2,460
Free Cash Flow
₹510

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
24 Oct 2024 Sharekhan Buy ₹1,534.65 ₹1,874 19.9% moneycontrol View
30 Jan 2024 Sharekhan ₹700.1 ₹800 -49.8% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,2.21-0.31NA-1.250
STRIDES PHARMA SCIENCE LIMITED5003.74133.474986.161.457,51720.1
Aarti Pharmalabs Limited3769.06512.213753.110746928.0
MARKSANS PHARMA LTD.3217.44480.563197.341.06744921.3

Peer Comparison Chart


About STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE LIMITED, with Security Code 532531, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Strides Pharma Science (NSEI:STAR) - Stock Analysis

(18 Sep 2025)
Research Strides Pharma Science's (NSEI:STAR) fundamentals, past performance, valuation, dividends and more.
Read more →

Strides inks strategic product development partnership with Kenox

(16 Sep 2025)
15 September 2025. More on this story... India and China vie for leadership in biotech and pharma R&D. Pharmaceutical.
Read more →

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for...

(10 Sep 2025)
Bangalore: Strides Pharma Science Ltd has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte.
Read more →

Strides Pharma, Kenox Team Up for US Nasal Spray Market; Shares Trading Flat

(10 Sep 2025)
Shares of Strides Pharma Science Ltd traded flat on 9th September after touching a day's high of Rs 894. This occurred even as the company...
Read more →

Kenox Enters into Strategic Product Development Partnership with Strides

(10 Sep 2025)
PRNewswire/ -- Strides Pharma Science Ltd today announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte.
Read more →

Strides Pharma partners with Kenox with eye on US nasal spray market

(09 Sep 2025)
Drug firm Strides Pharma Science Ltd on Monday (September 8) announced that its wholly-owned subsidiary, Strides Pharma Global Pte.
Read more →